innoVitroWe had a great time welcoming Tamara Zietek from Ärzte gegen Tierversuche e.V. at our headquarter in Jülich to show her innoVitro’s CRO service laboratories and technologies and to discuss new approach methodologies as a valid replacement for animal models.Continue readingMeeting with Ärzte gegen Tierversuche
The Nanion User Meeting will be held October 24 – 25 in Munich, Germany. Details will follow.Continue readingMeet us at the Nanion User Meeting
The ELRIG Drug Discovery Conference will be held October 18 – 19 in Liverpool, UK. Details will follow.Continue readingMeet us at ELRIG Drug Discovery
The Safety Pharmacology Society (SPS) meeting will be held Septemeber 18 – 21 at the SQUARE Brussels Meeting Centre in Belgium. Stop by our booth No. 505 as well as poster and oral presentations. SPS 2023 FLEXcyte Posters #095 In Vitro Systems for the Assessment of Chronic Cardiotoxic Effects: News from the HESI Stem Cell…Continue readingMeet us at the Safety Pharmacology Society Annual Meeting
We are happy to announce innoVitro’s CTO Peter Linder has been awarded the HESI (Health and Environmental Science Institute https://hesiglobal.org/) Cardiac Safety Committee Recognition Award 2022 – 2023 for his exceptional contributions to the Stem Cell Working Group.Continue readingCardiac Safety Committee Recognition Award 2022 -2023
The MPS conference will take place June 26 – 30, 2023 in the JW Marriott Hotel Berlin. Click here for more information https://mpsworldsummit.com/ and keep an eye out news coming soon!Continue readingMeet us at the 2nd Microphysiological System World Summit in Berlin, Germany!
With the New Year we are focussing on the importance of human iPSC-derived cardiomyocyte beat rate pacing for the analysis of drug effects. Hinata et al., 2022 investigated the relationship between contraction parameters and beating rates of cardiac cell sheet tissues by directly measuring the contraction force and compared the effects of ion channel drugs…Continue readinginnoVation Series December 22 / January 23
The SOT conference will take place in March 19 – 23, 2023. Keep an eye out for more information coming soon!Continue readingMeet us at the 62nd Society of Toxicology Annual Meeting in Nashville, USA
The October issue of the innoVation series is a special workshop report of the FDA (Pang et al., 2019) on improving cardiotoxicity assessment with human-relevant platforms. In detail, the urgent need to integrate human-relevant platforms/approaches into drug development to reduce cardiovascular safety liabilities were discussed, including potential regulatory applications of human-derived cardiomyocytes and future directions…Continue readinginnoVation Series October / November 2022
innoVitro has been recognized by GHP (Global Health & Pharma) as most innovative in vitro technology company in Germany for the year 2022. Read the interview with Matthias Gossmann, CEO of innoVitro hereContinue readinginnoVitro awarded as most innovative in vitro technology company in Germany
